IBDEI16C ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19054,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Chronic
 ;;^UTILITY(U,$J,358.3,19054,1,4,0)
 ;;=4^J82.81
 ;;^UTILITY(U,$J,358.3,19054,2)
 ;;=^24374
 ;;^UTILITY(U,$J,358.3,19055,0)
 ;;=J82.82^^64^845^7
 ;;^UTILITY(U,$J,358.3,19055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19055,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Acute
 ;;^UTILITY(U,$J,358.3,19055,1,4,0)
 ;;=4^J82.82
 ;;^UTILITY(U,$J,358.3,19055,2)
 ;;=^5159205
 ;;^UTILITY(U,$J,358.3,19056,0)
 ;;=J82.83^^64^845^6
 ;;^UTILITY(U,$J,358.3,19056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19056,1,3,0)
 ;;=3^Eosinophilic Asthma
 ;;^UTILITY(U,$J,358.3,19056,1,4,0)
 ;;=4^J82.83
 ;;^UTILITY(U,$J,358.3,19056,2)
 ;;=^5159206
 ;;^UTILITY(U,$J,358.3,19057,0)
 ;;=G89.22^^64^846^2
 ;;^UTILITY(U,$J,358.3,19057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19057,1,3,0)
 ;;=3^Chr Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,19057,1,4,0)
 ;;=4^G89.22
 ;;^UTILITY(U,$J,358.3,19057,2)
 ;;=^5004156
 ;;^UTILITY(U,$J,358.3,19058,0)
 ;;=G89.3^^64^846^4
 ;;^UTILITY(U,$J,358.3,19058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19058,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,19058,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,19058,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,19059,0)
 ;;=G89.18^^64^846^1
 ;;^UTILITY(U,$J,358.3,19059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19059,1,3,0)
 ;;=3^Acute Postprocedural Pain
 ;;^UTILITY(U,$J,358.3,19059,1,4,0)
 ;;=4^G89.18
 ;;^UTILITY(U,$J,358.3,19059,2)
 ;;=^5004154
 ;;^UTILITY(U,$J,358.3,19060,0)
 ;;=G89.29^^64^846^3
 ;;^UTILITY(U,$J,358.3,19060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19060,1,3,0)
 ;;=3^Chronic Pain
 ;;^UTILITY(U,$J,358.3,19060,1,4,0)
 ;;=4^G89.29
 ;;^UTILITY(U,$J,358.3,19060,2)
 ;;=^5004158
 ;;^UTILITY(U,$J,358.3,19061,0)
 ;;=J94.1^^64^847^1
 ;;^UTILITY(U,$J,358.3,19061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19061,1,3,0)
 ;;=3^Fibrothorax
 ;;^UTILITY(U,$J,358.3,19061,1,4,0)
 ;;=4^J94.1
 ;;^UTILITY(U,$J,358.3,19061,2)
 ;;=^5008317
 ;;^UTILITY(U,$J,358.3,19062,0)
 ;;=C45.0^^64^847^2
 ;;^UTILITY(U,$J,358.3,19062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19062,1,3,0)
 ;;=3^Pleura Mesothelioma
 ;;^UTILITY(U,$J,358.3,19062,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,19062,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,19063,0)
 ;;=J94.8^^64^847^4
 ;;^UTILITY(U,$J,358.3,19063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19063,1,3,0)
 ;;=3^Pleural Conditions NEC
 ;;^UTILITY(U,$J,358.3,19063,1,4,0)
 ;;=4^J94.8
 ;;^UTILITY(U,$J,358.3,19063,2)
 ;;=^5008319
 ;;^UTILITY(U,$J,358.3,19064,0)
 ;;=J94.9^^64^847^3
 ;;^UTILITY(U,$J,358.3,19064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19064,1,3,0)
 ;;=3^Pleural Condition,Unspec
 ;;^UTILITY(U,$J,358.3,19064,1,4,0)
 ;;=4^J94.9
 ;;^UTILITY(U,$J,358.3,19064,2)
 ;;=^5008320
 ;;^UTILITY(U,$J,358.3,19065,0)
 ;;=J91.8^^64^847^6
 ;;^UTILITY(U,$J,358.3,19065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19065,1,3,0)
 ;;=3^Pleural Effusion in Conditions Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19065,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,19065,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,19066,0)
 ;;=J90.^^64^847^5
 ;;^UTILITY(U,$J,358.3,19066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19066,1,3,0)
 ;;=3^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,19066,1,4,0)
 ;;=4^J90.
 ;;^UTILITY(U,$J,358.3,19066,2)
 ;;=^5008310
 ;;^UTILITY(U,$J,358.3,19067,0)
 ;;=J92.0^^64^847^7
